2025-09-04 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the data provided, formatted for a report, and including numerical summaries with interpretations:

## Procter & Gamble (PG) Stock Analysis

**Company Overview:** Procter & Gamble Co (PG) is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.

### 1. Performance vs. S&P 500 (VOO)

*   **PG Cumulative Return:** 45.99%
*   **VOO Cumulative Return:** 99.17%
*   **Absolute Divergence:** -53.18%
*   **Divergence Range:** Max: 29.9, Min: -58.5
*   **Relative Divergence:** 0.7

**Analysis:** PG has significantly underperformed the S&P 500 (VOO) over the period examined. The relative divergence of 0.7 suggests PG's underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta  | Cap(B) |
|------------|---------|---------|--------|-------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%  | 0.0   | 215.2  |
| 2016-2018  | 5.0%    | 56.7%   | -13.0% | 0.1   | 215.3  |
| 2017-2019  | 30.0%   | 56.7%   | 0.0%   | 0.5   | 292.6  |
| 2018-2020  | 38.0%   | 59.1%   | 18.0%  | 0.3   | 325.9  |
| 2019-2021  | 56.0%   | 59.1%   | 8.0%   | 0.3   | 383.2  |
| 2020-2022  | 24.0%   | 74.7%   | 22.0%  | 0.3   | 355.0  |
| 2021-2023  | 30.0%   | 74.7%   | 12.0%  | 0.3   | 343.3  |
| 2022-2024  | 8.0%    | 74.7%   | -17.0% | 0.3   | 392.7  |
| 2023-2025  | -14.0%  | 71.6%   | -65.0% | 0.2   | 368.9  |

**Analysis:**

*   **CAGR:** Fluctuating CAGR indicates periods of strong growth and recent declines.
*   **MDD:** High MDD values across all periods suggest significant downside risk.
*   **Alpha:** Negative alpha values indicate underperformance relative to the benchmark, especially in recent periods (2022-2025).
*   **Beta:** Beta values consistently below 1 suggest lower volatility than the market.
*   **Cap:** Market capitalization shows general growth, though with some fluctuation.

### 2. Recent Stock Price Movements

*   **Current Price:** 157.4762
*   **Last Market Data:** Price: 157.46, Previous Close: 157.99, Change: -0.34
*   **5-Day Moving Average:** 156.6192
*   **20-Day Moving Average:** 155.7113
*   **60-Day Moving Average:** 157.2783

**Analysis:** The current price is slightly below the previous close, indicating a small recent decline. The 5-day and 20-day moving averages are below the 60-day moving average, suggesting a potential short-term downward trend.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3403 (Low Risk)
*   **RSI:** 57.73 (Neutral)
*   **PPO:** 0.1384 (Neutral)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (5 shares - Caution - MRI:0.34) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Recent (20-day) Relative Divergence Change:** -6.1 (Negative - Short-term Decrease)
*   **Expected Return:** 700.1% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a low level of market risk.
*   The RSI is near the neutral level, not indicating overbought or oversold conditions.
*   The negative change in relative divergence indicates recent underperformance compared to the S&P 500.
*   The Hybrid Signal suggests a cautious buy approach with monthly investment, given the low MRI.
*   The high expected return suggests significant potential for outperformance over the long term.
*   The recent price change of -0.34, while small, aligns with the negative divergence and downward trend indicated by the moving averages.

### 4. Recent News & Significant Events

*   **2025-08-31:** Major business developments, regulatory changes, or market events.
*   **2025-09-01:** Analysts discussing recent performance in the context of industry and global economics.
*   **2025-09-03:** Notable stock volatility.
*   **2025-09-02:** Market experts highlighting risks and opportunities, advising investors to monitor news.

**Analysis:** The news indicates recent volatility and market attention on PG, with analysts discussing performance and outlook. Investors should monitor news and company announcements.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2024-04-19 | 1.56 | 20.20 B$    |
| 2025-04-24 | 1.56 | 20.20 B$    |

**Analysis:** The table presents a mixture of EPS and revenue figures, some seemingly duplicated or potentially out of order. A consistent reporting format would be more helpful. Generally, there's fluctuation in both EPS and revenue.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $20.89B  | 49.11%        |
| 2025-03-31   | $19.78B  | 50.98%        |
| 2024-12-31   | $21.88B  | 52.39%        |
| 2024-09-30   | $21.74B  | 52.06%        |
| 2024-06-30   | $20.53B  | 49.60%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE     |
|--------------|----------|---------|
| 2025-06-30   | $52.01B  | 6.95%   |
| 2025-03-31   | $52.27B  | 7.21%   |
| 2024-12-31   | $51.17B  | 9.05%   |
| 2024-09-30   | $51.84B  | 7.64%   |
| 2024-06-30   | $50.29B  | 6.24%   |

**Analysis:**

*   **Revenue:** Revenue shows some fluctuation, with a peak in late 2024.
*   **Profit Margin:** Profit margins are consistently high, indicating strong profitability.
*   **Equity:** Equity has been relatively stable.
*   **ROE:** ROE has varied, with a peak in late 2024, reflecting the higher revenue and earnings during that period.

### 7. 종합 Summary

PG has underperformed the S&P 500, with recent technical indicators suggesting a short-term downward trend. Financial data indicates strong profitability but fluctuating revenue and ROE. News indicates recent volatility and market attention. The hybrid signal advises a cautious buy approach with monthly investment and a long term expectation of substantial out performance. The high MDD indicates high downside risks, but MRI indicates a low market risk, and the recent (20-day) relative divergence indicates a short term decrease.

**Overall Recommendation:** Given the mixed signals, a cautious approach is warranted. Investors should monitor news, company announcements, and continue to evaluate financial performance before making significant investment decisions.
